{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:25:37Z","timestamp":1790691937269,"version":"4.1.0"},"reference-count":42,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2018.4513","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T08:56:46Z","timestamp":1533113806000},"source":"Crossref","is-referenced-by-count":4,"title":["Anti-adult T\u2011cell leukemia\/lymphoma activity of cerdulatinib, a dual SYK\/JAK kinase inhibitor"],"prefix":"10.3892","author":[{"given":"Chie","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Department of Microbiology and Oncology, Graduate School of Medicine, University of The Ryukyus, Nishihara, Okinawa 903-0215, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masachika","family":"Senba","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Oncology, Graduate School of Medicine, University of The Ryukyus, Nishihara, Okinawa 903-0215, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"key20200713185144_b1-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: A review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front Microbiol"},{"key":"key20200713185144_b2-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3960\/jslrt.17008","article-title":"Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma","volume":"57","author":"Katsuya","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"key20200713185144_b3-ijo-53-04-1681","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4049\/jimmunol.142.7.2279","article-title":"Human T cell leukemia\/lymphoma virus type I infection of a CD4+ proliferative\/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells","volume":"142","author":"Yssel","year":"1989","journal-title":"J Immunol"},{"key":"key20200713185144_b4-ijo-53-04-1681","first-page":"25","article-title":"Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases","volume":"27","author":"Miyazaki","year":"1996","journal-title":"Cancer Surv"},{"key":"key20200713185144_b5-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key20200713185144_b6-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.7604283","article-title":"Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I","volume":"269","author":"Migone","year":"1995","journal-title":"Science"},{"key":"key20200713185144_b7-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1172\/JCI118193","article-title":"Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells","volume":"96","author":"Xu","year":"1995","journal-title":"J Clin Invest"},{"key":"key20200713185144_b8-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","article-title":"Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins","volume":"94","author":"Takemoto","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185144_b9-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1182\/blood-2010-09-305425","article-title":"CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM\/TSP","volume":"117","author":"Ju","year":"2011","journal-title":"Blood"},{"key":"key20200713185144_b10-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"12480","DOI":"10.1073\/pnas.1516208112","article-title":"Selective targeting of JAK\/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185144_b11-ijo-53-04-1681","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1128\/JVI.73.5.3709-3717.1999","article-title":"Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines","volume":"73","author":"Weil","year":"1999","journal-title":"J Virol"},{"key":"key20200713185144_b12-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1124\/jpet.114.218164","article-title":"The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer","volume":"351","author":"Coffey","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"key20200713185144_b13-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"43881","DOI":"10.18632\/oncotarget.6316","article-title":"Cerdulatinib, a novel dual SYK\/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713185144_b14-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1158\/1078-0432.CCR-16-1662","article-title":"The dual Syk\/JAK inhibitor cerdulatinib antagonizes B-cell receptor and microenvironmental signaling in chronic lymphocytic leukemia","volume":"23","author":"Blunt","year":"2017","journal-title":"Clin Cancer Res"},{"key":"key20200713185144_b15-ijo-53-04-1681","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.18632\/oncotarget.14588","article-title":"Dual SYK\/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185144_b16-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-017-0512-1","article-title":"Syk inhibitors in clinical development for hematological malignancies","volume":"10","author":"Liu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"key20200713185144_b17-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ijc.2910620112","article-title":"Radiation-induced apoptosis in human sarcoma and glioma cell lines","volume":"62","author":"Stapper","year":"1995","journal-title":"Int J Cancer"},{"key":"key20200713185144_b18-ijo-53-04-1681","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood.V87.8.3410.bloodjournal8783410","article-title":"Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins","volume":"87","author":"Mori","year":"1996","journal-title":"Blood"},{"key":"key20200713185144_b19-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/ijo.2017.4026","article-title":"Butein inhibits NF-\u03baB, AP-1 and Akt activation in adult T-cell leukemia\/lymphoma","volume":"51","author":"Ishikawa","year":"2017","journal-title":"Int J Oncol"},{"key":"key20200713185144_b20-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20200713185144_b21-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: A crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"key20200713185144_b22-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.yexcr.2013.05.018","article-title":"Tetramethylpyrazine attenuates TNF-\u03b1-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-I\u03baB signaling pathways","volume":"319","author":"Zheng","year":"2013","journal-title":"Exp Cell Res"},{"key":"key20200713185144_b23-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"e42610","DOI":"10.1371\/journal.pone.0042610","article-title":"Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas","volume":"7","author":"Hatton","year":"2012","journal-title":"PLoS One"},{"key":"key20200713185144_b24-ijo-53-04-1681","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.4049\/jimmunol.162.7.3897","article-title":"JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response","volume":"162","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"key20200713185144_b25-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"key20200713185144_b26-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"key20200713185144_b27-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2184.2011.00753.x","article-title":"Cdc2: A monopotent or pluripotent CDK?","volume":"44","author":"Hu","year":"2011","journal-title":"Cell Prolif"},{"key":"key20200713185144_b28-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(00)80994-0","article-title":"Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity","volume":"84","author":"Guadagno","year":"1996","journal-title":"Cell"},{"key":"key20200713185144_b29-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11010-017-3082-1","article-title":"Activator protein-1 (AP-1): A bridge between life and death in lung epithelial (A549) cells under hypoxia","volume":"436","author":"Yadav","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"key20200713185144_b30-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.1074\/jbc.M116.770420","article-title":"\u03b2-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2\/M phase transition","volume":"292","author":"Zhang","year":"2017","journal-title":"J Biol Chem"},{"key":"key20200713185144_b31-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"key20200713185144_b32-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-2187-5-10","article-title":"Inhibition of PI3K\/AKT and MAPK\/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer","volume":"5","author":"Roy","year":"2010","journal-title":"J Mol Signal"},{"key":"key20200713185144_b33-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0014-5793(00)01416-2","article-title":"MAPK-dependent expression of p21(WAF) and p27(kip1) in PMA-induced differentiation of HL60 cells","volume":"472","author":"Das","year":"2000","journal-title":"FEBS Lett"},{"key":"key20200713185144_b34-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00280-002-0522-7","article-title":"Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy","volume":"50","author":"Kim","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20200713185144_b35-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1128\/MCB.21.24.8247-8254.2001","article-title":"FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis","volume":"21","author":"Krueger","year":"2001","journal-title":"Mol Cell Biol"},{"key":"key20200713185144_b36-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00001622-199911000-00010","article-title":"STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription","volume":"11","author":"Catlett-Falcone","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"key20200713185144_b37-ijo-53-04-1681","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185144_b38-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb1005","article-title":"Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK","volume":"5","author":"Allan","year":"2003","journal-title":"Nat Cell Biol"},{"key":"key20200713185144_b39-ijo-53-04-1681","first-page":"1862","article-title":"XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells","volume":"61","author":"Asselin","year":"2001","journal-title":"Cancer Res"},{"key":"key20200713185144_b40-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/A:1027385417793","article-title":"PKB phosphorylation and survivin expression are cooperatively regulated by disruption of microfilament cytoskeleton","volume":"254","author":"Liang","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"key20200713185144_b41-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1038\/sj.onc.1210094","article-title":"Regulation of survivin expression by IGF-1\/mTOR signaling","volume":"26","author":"Vaira","year":"2007","journal-title":"Oncogene"},{"key":"key20200713185144_b42-ijo-53-04-1681","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hon.2437_61","article-title":"The dual SYK\/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed\/refractory B-cell malignancies","volume":"35","author":"Hamlin","year":"2017","journal-title":"Hematol Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T02:50:49Z","timestamp":1693795849000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2018.4513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":42,"URL":"https:\/\/doi.org\/10.3892\/ijo.2018.4513","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}